|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries. |
| 公司地址
| 32 Wiggins Avenue, Bedford, MA, USA, 01730 |
| 電話號碼
| +1 781 457-9000 |
| 傳真號碼
| +1 781 305-9720 |
| 公司網頁
| https://www.anika.com |
| 員工數量
| 235 |
| Mr. Stephen D. Griffin |
President, Chief Executive Officer, Director, Executive Vice President, Chief Financial Officer and Chief Operating Officer |
美元 278.85K |
08/01/2026 |
| Mr. Ian James Winward McLeod |
Vice President, Chief Accounting Officer and Treasurer |
-- |
28/04/2025 |
| Mr. David B. Colleran |
Executive Vice President, General Counsel and Secretary |
美元 482.00K |
26/02/2026 |
|
|
| Dr. Cheryl R. Blanchard, PhD |
Executive Chairman of the Board |
08/01/2026 |
| Ms. Sheryl L. Conley |
Independent Director |
28/04/2025 |
| Mr. John B. Henneman, III |
Chairman of the Board |
28/04/2025 |
| Mr. Joseph H. Capper |
Independent Director |
28/04/2025 |
| Mr. Stephen D. Griffin |
President, Chief Executive Officer, Director, Executive Vice President, Chief Financial Officer and Chief Operating Officer |
08/01/2026 |
| Mr. Gary P. Fischetti |
Independent Director |
28/04/2025 |
| Mr. William R. Jellison |
Independent Director |
28/04/2025 |
| Dr. Glenn R. Larsen, PhD |
Independent Director |
28/04/2025 |
| Mr. Stephen O. Richard |
Independent Director |
28/04/2025 |
|
|
|
|
